The risks of not intervening in pre-onset psychotic illness

References

• Cuzik, J. (2000). Future Possibilities in the prevention of breast cancer: breast cancer prevention trials. Breast Cancer Research, 2(4), 258–263.
   PubMedGoogle Scholar
• Cuzik, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S. & Boyle, P. (2003). Overview of the main outcomes in breast-cancer prevention trials. Lancet, 36/(9354), 296— 300.
   Google Scholar
• Falloon, I.R.H. (1992). Early identification for first episodes of schizophrenia: A preliminary exploration. Psychiatry, 55, 4 — 15.
   PubMedGoogle Scholar
• Hafner, H. & van der Heiden, W. (1997). Epidemiology of schizophrenia. Canandian Journal of Psychiatry, 42, 139 — 151.
   Google Scholar
• Hawkins, K.A., Addington, J., Christensen, B., Keefe, R. & McGlashan, T.H. (2002). Neu-ropsychological status of the first episode prodrome. Symposium, Third International Conference on Early Psychosis, Sept 25-28, 2002 Copenhagen. Acta Psychiatrica Scandi-navica, 106(413), 43.
   Google Scholar
• McFarlane, W.R. (2003). The Multifamily Group. New York: Guilford Press, in press.
   Google Scholar
• McGlashan, T.H. (2001). Psychosis treatment prior to psychosis onset: ethical issues. Schizo-phrenia Research, 51, 47–54.
   PubMed Web of Science ®Google Scholar
• McGlashan, T.H. & Hoffman, R.E. (2000). Schizophrenia as a disorder of developmen-tally reduced synaptic connectivity. Archives of General Psychiatry, 57, 637–648.
   PubMed Web of Science ®Google Scholar
• McGlashan, T.H. & Johhannessen, J.0. (1996). Early detection and intervetion with shcizo-phrenia: Rationale. Schizophrenia Bulletin, 22(2), 201 — 222.
   Google Scholar
• McGlashan, T.H., Miller, T.J. & Woods, S.W. (2001). Pre-onset detection and intervention research in schizophrenic psychosis: Current estimates of benefit and risk. Schizophrenia Bulletin, 27(4), 563 — 570.
   Google Scholar
• McGlashan, T.H., Zipursky, R.B., Perkins, D., Addington, J., Miller, Ti., Woods, S.W., Hawkins, K.A., Hoffman, R., Lindborg, S., Tohen, M. & Breier, A. (2003). The PRIME North America randomized double-blind clin-ical trial of olanzapine vs placebo in patients at risk for being prodromally symptomatic for psychosis: I. Study rationale and design. Schizophrenia Research, 61, 7–18.
   Google Scholar
• Miller, Ti., Woods, S.W., Rosen, J.L. & McGla-shan, T.H. (2002). Treatment of schizophrenic psychosis at onset (letter). American Journal of Psychiatry, 159(1), 153.
   Google Scholar
• Miller, Ti., Zipursky, R.B., Perkins, D., Adding-ton, J., Woods, S.W., Hawkins, K.A., Hoff-man, R., Preda, A., Epstein, I., Addington, D., Lindborg, S., Marquez, E., Tohen, M., Breier, A. & McGlashan, T.H., (2003). The PRIME North America randomized double-blind clin-ical trial of olanzapine vs placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the 'prodromal' sample. Schizophrenia Research, 61, 19 — 30.
   Google Scholar
• Preda, A., Miller, T.J., McGlashan, T.H. & Woods, S.W. (2002). Treatment history of patients in schizophrenic prodromal states. Psychiatric Services, 53(3), 342— 344.
   Google Scholar
• Rosen, J.L., Woods, S.W., Miller, T.J. & McGla-shan, T.H. (2002). Prospective observations of emerging psychosis. The Journal of Nervous and Mental Disorders, 190, 133–141.
   PubMedGoogle Scholar
• Woods, S.W., Breier, A., Zipursky, R.B., Per-kins, DO., Addington, J., Miller, Ti., Hawkins, K.A., Marquez, E., Lindborg, S.R., Tohen, M. & McGlashan, T.H. (2003). Randomized trial of olanzapine vs placebo in the symptomatic acute treatment of patients meeting criteria for the schizphre-nia prodrome. Biological Psychiatry (in press).
   Google Scholar
• Yung, A.R., McGorry, P.D., McFarlane, C.A., Jackson, Hi., Patton, G.C. & Rakkar, A. (1996). Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22(2), 283–303.
   Google Scholar
• Yung, A., Phillips, L., McGorry, P., McFarlane, C., Francey, S. & Harrigan, S. (1998). Predic-tion of psychosis. British Journal of Psychiatry, /72\(suppl. 33), 14–20.
   Google Scholar